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Conclusions: EPID-based in vivo dosimetry was successfully 
implemented across 4 cancer centres. Results were comparable with 
those of alternative approaches but without increasing the time 
required for the treatment appointment. Detailed understanding of 
the equipment involved is important when relying on EPIDs for 
dosimetry. A dedicated team of champions is essential for driving 
forward changes to existing workflows. EPIDs can successfully be 
utilised for photon output checks. 
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Purpose/Objective: The main objective of this work was to model an 
electronic portal imaging devices (EPID) in a commercial Treatment 
Planning System (TPS). An EPID based transmitted dose verification 
model was developed to predict transmitted doses. This model 
enables the verification of two dimensional dose distribution in EPID 
level for a step and shoot intensity modulated radiation therapy 
(IMRT) technique using a SIEMENS Optivue 1000ST amorphous silicon 
portal imaging device. The model is user-friendly and does not involve 
complicating and time consuming analytical methods. 
Materials and Methods: A homogeneous PMMA phantom was scanned 
using a CT scanner. The CT scan of this phantom was transferred via 
DICOM files to the planning system. The central pixel response and 
profile characteristics were investigated to find the best EPID model 
in the TPS. To remove the effect of different sensitivity of EPID pixels, 
the flood field images have been obtained and used for correcting 
images. Portal images for several rectangular fields at different 
phantom thicknesses obtained to correct the field size dependency of 
the EPID detector. A two dimensional array of ionization chambers 
were used as reference for dose calibration of EPID portalimages at a 
specific depth; dref which the EPID dose profiles were best matched 
with the corresponding dose profiles measured in water in the TPS. 
Results: Predicted transmitted dose maps of 7 IMRT pelvic cases in a 
Phantom in EPID model were generated in the treatment planning 
system using collapsed cone algorithm. Predicted transmitted dose 
maps were compared with the corresponding two dimensional 
measured calibrated dose map using a calibrated EPID. Gamma 
analysis was used for comparison of predicted and measured dose 
maps. Results showed that approximately more than 95% of points in 
the dose maps of IMRT fields were in agreement with a 4% dose and 4 
mm distance criteria. 
Conclusions: The current technique can be applied for clinical dose 
verification as a simple and fast assessment method to verify IMRT 
treatments.  
   
EP-1145   
Development and assessment of an in-house program for 
calculating the monitor unit in proton therapy. 
N. Hayashi1, Y. Watanabe2, Y. Adachi2, N. Manabe2, S. Yoshimura2, I. 
Ehara2, H. Kato2 
1Fujita Health University School of Medicine, Academic Physics, 
Toyoake, Japan  
2Fujita Health University School of Health Sciences, Radiological 
Technology, Toyoake, Japan  
  
Purpose/Objective: The purpose of this research is to develop and 
verify an in-house program to calculate the monitor unit (MU) for 
proton therapy system equipped with the range modulation wheel 
(RMW). 
Materials and Methods: The MU calculation for the proton beam was 
suggested by Sahoo et al. in 2008 and given by the formalism using the 
multiplication of several factors with regard to the structure of the 
proton beam system. We adopted their theory and used eight factors 
in the equation for creating the program as follows: Relative output 
factor (ROF), Spread-out Braggpeak factor (SOBPF), Range shifter 
factor (RSF), SOBP off-center factor(SOBPOCF), Off-center ratio 
(OCR), Field size factor (FSF), Inverse square factor (ISF), and 
Compensator and patient scatter factor (CPSF). The program was built 
by Microsoft Visual Basic on Windows personal computer. After 
building the program, the calculated doses were compared with the 
measured dose. The referential dose was calibrated with an ionization 
chamber placed at the isocenter with a fixed source-to-detector 
distance (SDD) of 270 cm. 
Results: The program was created by Visual Basic ver.6.0 and verified 
under the environment of Windows 7 OS, 4 GB memory, 2.5GHz CPU. 
It was simply and satisfactory fast for the user to complete calculating 
(dose/MU). The graphical user interface (GUI) of our program is shown 
in Figure.1. The dose/MU was calculated by the equation with the 
multiplication using eight factors. The equation was given by: 
(dose/MU)=ROF*SOBPF*RSF*SOBPF*OCR*FSF*ISF*CPSF. Once the energy 
and the radiation field settings were input to the program, these 
factors were estimated from the referential measured data. Then MU 
calculation was done immediately. As the results of the comparison 
between the measured and calculated doses, the errors between the 
calculated and measured doses in all referential settings were within 
2%. Our program was able to calculate MU accurately in simple field 
settings. However, the errors in complicated radiation fields were 
larger than those of simple fields. In particular, ROF and SOBPF were 
commonly factors leading to large changes in d/MU. 
 
 
Figure 1. The main menu in our in-house program. 
 
Conclusions: The in-house program provides the fast MU calculation 
for proton beams as an independent check. The accuracy of the dose 
calculation is good in the referential settings at SDD of 270 cm. 
However, further improvement is required for the complicated 
settings.  
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Purpose/Objective: At the present, IMRT is a standard treatment 
modality and VMAT is becoming an increasingly common delivery 
technique; the complexity of these techniques makes patient-specific 
verification to be considered a prerequisite to patient treatment. 
Characteristics of modern EPIDs along with specific developed 
algorithms to process EPID response make these devices promising 
candidates for such dosimetry. The purpose of this work is to describe 
our initial experience using Varian® Portal Dosimetry in patient-
specific pretreatment verifications of RapiArc (RA) treatments. 
Materials and Methods: Our department has recently (February 2012) 
been equipped with 3 Varian linac’s (2 Clinac’s, 1 TrueBeam), in 
which a large part of the treatments are delivered with IMRT, mostly 
RA; dose distribution calculations are performed with Eclipse™ 
treatment planning system (10.0). The three linacs come with EPID 
sytems and Portal Dosimetry software (10.0) that allows for 
comparison between predicted images and acquired ones. The 
software is based on the EPID response calibration and a pencil beam-
based algorithm (PDIP) that predicts the system response. Our IMRT 
verification protocol includes Portal Dosimetry as one of the patient-
specific verification tools; one predicted image is generated for each 
of the arcs used; a calibration 10x10 static field is acquired prior to 
the verification in order to account for eventual minor changes in the 
detector response or linac output; for comparison,local gamma index 
(3%/3mm) is used discarding doses below a 10% threshold. The points 
passing rate is evaluated to assess the acceptability of the plan. 
